Importantly, the oncogenic roles of CDK4/6 and YAP1 have been identified not only in HCC, but also in many other cancers, including breast cancer [22, 47], esophageal cancer [34, 48], pancreatic ductal adenocarcinoma [35, 49]. This evidence concerns the gene CDK4 and hepatocellular carcinoma.